Valiant Laboratories Ltd Share Price

Q: What is the share price of Valiant Laboratories Ltd today?

Valiant Laboratories Ltd share price as on 12 Jun 2026 is ₹68.25

Pharmaceuticals

NSE: VALIANTLAB Small Cap ISIN: INE0JWS01017

As on 13 June 2026 at 02:27 IST

₹68.25

+ 1.22

(1.82%)

Sell Buy

Over 1 Month

-14.61%

Over 6 Months

0.71%

Over 1 Year

-39.37%

Over 3 Years

-57.61%

Valiant Laboratories Ltd Summary

Close ₹67.03

Open ₹69.99

High ₹71.79

Low ₹66.50

Volume 16,417

Net Turnover (in Cr) ₹0.11

52Wk High ₹115.54

52Wk Low ₹49.51

52Wk High / Low

49.51

115.54

Valiant Laboratories Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹364.06

EPS (TTM) 1.02

Book Value (BV) 58.87

Div. Yield -

P/E (TTM) 65.86

Price/Book Value 1.14

Delivery % -

Face Value 10

Key Ratios

PE Ratio -

PB Ratio 1.42

EV to Sales 2.75

PEG Ratio -

ROA -0.73

ROE -1.40

Debt-Equity 0.25

Net Profit Margin -2.47

Operating Profit Margin -0.82

Valiant Laboratories Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023
Total Revenue	138.82	191.74	338.77
Total Expenses	140.33	192.51	300.64
Profit Before Tax	-1.51	-0.77	38.14
Profit After Tax	-2.20	0.32	29
Operating Profit After Depreciation	-1.34	-0.69	38.39

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023
Fixed Assets	48.44	50.05	48.12
Total Non Current Assets	208.24	117.14	62.39
Total Current Assets	192.62	225.54	150.58
Total Assets	400.86	342.69	212.97
Total Shareholder's Fund	234.31	236.86	100.49

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023
Net Cash From Operating Activities	1.31	1.89	56.05
Net Cash Used In Investing Activities	-52.77	-143.88	-55.17
Net Cash Used In Financing Activities	44.65	152.45	-0.93

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	138.79	191.73	338.77	293.47	183.78
Total Expenses	140.24	192.49	300.64	251.77	136.76
Profit Before Tax	-1.45	-0.75	38.14	41.70	47.02
Profit After Tax	-2.15	0.34	29	27.50	30.59
Operating Profit After Depreciation	-1.27	-0.67	38.39	41.78	48.81

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	30.02	31.61	29.97	22.23	19.79
Total Non Current Assets	198.06	115.46	30.80	25.02	20.42
Total Current Assets	119.22	209.27	181.96	156.80	85.89
Total Assets	317.28	324.73	212.76	181.81	106.31
Total Shareholder's Fund	234.38	236.88	100.49	71.46	88.58

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	-21.90	48.78	22.96	2.25	9.11
Net Cash Used In Investing Activities	24.97	-182.73	-21.18	-12.24	-16.67
Net Cash Used In Financing Activities	-0.50	135.80	-1.53	6.18	11.43

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	91.98	52.46	46.20	46.82	57.79
Total Expenses	87.17	53.35	46.13	44.43	53.96
Profit Before Tax	1.04	-2.99	0.27	2.45	0.95
Profit After Tax	1.76	-7.06	0.20	1.82	0.70
Operating Profit after Depreciation	4.98	-0.26	0.94	3.05	1.52

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	65.30	54.74	45.99	51.01	57.77
Total Expenses	60.80	54.49	45.93	48.65	53.94
Profit Before Tax	4.73	0.11	0.26	2.45	3.92
Profit After Tax	3.53	0.03	0.17	1.82	3.24
Operating Profit after Depreciation	5.27	0.86	0.91	3.03	4.48

Valiant Laboratories Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 65.09

S2 63.15

S3 59.80

Pivot 68.44

R1 70.38

R2 73.73

R3 75.67

Moving Average

20 SMA 75.65

50 SMA 71.57

100 SMA 64.99

200 SMA 71.88

Valiant Laboratories Ltd Corporate Actions

No available data

Valiant Laboratories Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

Valiant Laboratories Ltd Top Mutal Funds Invested

No data available

Valiant Laboratories Ltd News

Valiant Laboratories to discuss results

On 14 May 2026

11 May 2026, 05:37 pm

Valiant Laboratories to hold board meeting

On 11 February 2026

06 Feb 2026, 05:05 pm

Valiant Laboratories to table results

On 11 November 2025

07 Nov 2025, 02:01 pm

Valiant Laboratories AGM scheduled

On 25 September 2025

03 Sep 2025, 03:23 pm

Valiant Laboratories to hold board meeting

On 8 August 2025

06 Aug 2025, 03:29 pm

Valiant Laboratories Ltd Stock Analysis

Annual revenue for Valiant Laboratories Ltd decreased by 27.61% to ₹138.79 crore in FY 2025 from ₹191.73 crore in FY 2024.
Annual Net Profit for Valiant Laboratories Ltd decreased by 731.85% to ₹-2.15 crore in FY 2025 from ₹0.34 crore in FY 2024.
Promoter Shareholding in Valiant Laboratories Ltd remains unchanged by 0.00% in the most recent quarter, from 74.94% in December 2025 to 74.94% in March 2026.
Valiant Laboratories Ltd delivered a 1-year return of -39.37% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Valiant Laboratories Ltd share price moved up by 1.82% from its previous close of INR ₹67.03. The latest Valiant Laboratories Ltd share price is INR ₹68.25.
Valiant Laboratories Ltd share price today has been at a low of 67 and a high of 69. Over the past 52 weeks, the Valiant Laboratories Ltd share price has seen a low of 49.51 and a high of 115.54.